Revenue Performance - Total revenue for the first quarter of 2023 increased by 15.5% at constant exchange rates, amounting to HKD 4,969 million, with HKD 4,071 million from the tissue segment and HKD 898 million from personal care[2] Profitability Metrics - Gross profit decreased by 17.1% to HKD 1,254 million, with a gross profit margin narrowing by 7.9 percentage points to 25.2%[2] - Operating profit fell by 85.4% to HKD 65 million, with the operating profit margin contracting by 8.5 percentage points to 1.3%[2] - EBITDA decreased by 47.2% to HKD 412 million, with an EBITDA margin of 8.3%, down by 8.8 percentage points[2] - Net profit decreased by 88.4% to HKD 40 million, with a net profit margin declining by 6.7 percentage points to 0.8%[2] Foreign Exchange Impact - The total foreign exchange loss amounted to HKD 7.7 million, compared to a gain of HKD 11.8 million in the same period last year[2]
维达国际(03331) - 2023 Q1 - 季度业绩